Title

Multicenter automatic defibrillator implantation trial–subcutaneous implantable cardioverter defibrillator (madit s-icd): Design and clinical protocol

Document Type

Conference Proceeding

Publication Date

2017

Abstract

Patients with diabetes mellitus, prior myocardial infarction, older age, and a relatively preserved left ventricular ejection fraction remain at risk for sudden cardiac death that is potentially amenable by the subcutaneous implantable cardioverterdefibrillator with a good risk-benefit profile. The launched MADIT S-ICD study is designed to test the hypothesis that post–myocardial infarction diabetes patients with relatively preserved ejection fraction of 36%-50% will have a survival benefit from a subcutaneous implantable cardioverter defibrillator.

Volume

189

First Page

158

This document is currently not available here.

Share

COinS